shuang zhang

Shuang holds an MBA from the University of West Florida and a BA in English Language and Literature from Peking University. 

​

Shuang loves neuroscience and is passionate about neuroplasticity and positive psychology. She is also an avid rockhound and spent most of her spare time collecting rocks and minerals.

Most recently, Shuang was the Principal of Cenova Ventures, a boutique venture capital firm dedicated to investments in life science and healthcare in China. Shuang helped Cenova with fundraising, cross-border partnerships, and investor relationships. 

​

Prior to Cenova, Shuang spent almost 20 years helping U.S. life science companies identify partners and set up operations in China. She served as the Business Development director for Acidophil LLC, which was founded by Nobel Laureate Sydney Brenner and Philip Goelet to focus on biotechnologies that address unmet market needs. Before that, she was the VP of Operational Liaison for Medicilon/MPI Preclinical Research-Shanghai, a joint venture sponsored by the world's largest single-site preclinical research company. Shuang also served as the Business Development Director for Bridge Pharmaceuticals, the first US contract research organization (CRO) to outsource preclinical drug development in Asia. Early in her career, Shuang worked as an international project coordinator at the Chinese Ministry of Agriculture.

As a member of Class 20, Shuang served her fellowship at Cenova Ventures under the mentorship of Dr. Jun Wu, the firm's Founder, Chairman, and Managing Partner, as well as Philip Goelet of Red Abbey Venture Partners.